Horan Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-182
Closed -$85.2K 409
2023
Q2
$85.2K Buy
182
+1
+0.6% +$419 0.04% 187
2023
Q1
$62.3K Sell
181
-30
-14% -$10.1K 0.03% 194
2022
Q4
$77.1K Buy
211
+162
+331% +$57.4K 0.04% 166
2022
Q3
$16K Sell
49
-49
-50% -$15.5K 0.01% 299
2022
Q2
$32K Buy
98
+48
+96% +$14.4K 0.02% 216
2022
Q1
$14K Buy
50
+1
+2% +$257 0.01% 288
2021
Q4
$14K Buy
+49
New +$12.4K 0.01% 287
2021
Q2
$7K Hold
29
0.01% 335
2021
Q1
$5K Buy
29
+13
+81% +$2.54K ﹤0.01% 322
2020
Q4
$3K Sell
16
-14
-47% -$2.09K ﹤0.01% 339
2020
Q3
$4K Buy
+30
New +$4.64K ﹤0.01% 276

Other funds holding LLY

Horan Securities's LLY Position: Q3 2023 in Review

Horan Securities sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 182 shares — an estimated $85.2K sold.

Horan Securities first reported a position in LLY in Q3 2020 and held it in 11 quarters. The position peaked at $85.2K in Q2 2023. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • Horan Securities reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 182 Eli Lilly shares in Q3 2023, an estimated $85.2K.
  • Horan Securities first reported a position in Eli Lilly in Q3 2020 and held it in 11 quarters.
  • Horan Securities's Eli Lilly position peaked at $85.2K in Q2 2023.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.